Overall rank by patents
#22,175
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 7 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H10D (INORGANIC ELECTRIC SEMICONDUCTOR DEVICES).
The verdict
According to USPTO PatentsView, Amorphyx ranks #22,175 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R22175 · US Corporation #22,175 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Altimmune Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Shazam Investments · near
34 score
Woodward L'orange · near
34 score
Amorphyx Incorporated · this assignee
34 score
Arcadia Biosciences · near
34 score
Hmicro · near
34 score
3D Lighting Innovati… · lowest
7 score
What this shows Amorphyx's Innovation Score is 33.8/100 (top 55% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Amorphyx, Incorporated is a focused PatentsView assignee: 7 CPC subclasses with 75% of grants classified under H10D (INORGANIC ELECTRIC SEMICONDUCTOR DEVICES). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2019. By volume, Amorphyx sits between Altimmune Inc. and Andritz Technology And Asset Management Gmbh.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Altimmune Inc.
12 patents
Amann Girrbach AG
12 patents
Amastan Technologies Inc.
12 patents
Amneal Complex Products Research LLC
12 patents
Ample, Inc.
12 patents
Analogix Semiconductor, Inc.
12 patents
And.B, LLC
12 patents
Andritz Technology and Asset Management GmbH
12 patents
Amorphyx, Incorporated
12 patents
What this shows Amorphyx holds 12 patents at rank #22,209, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #22,209 in granted patent volume.
Other assignees with the most granted patents in Amorphyx's primary technology class.
Two PlainPatent-derived peer sets for Amorphyx, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (34 here).
Amorphyx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 Top 55% higher than 45% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 8.3% |
| 2020 | 2 | 16.7% |
| 2021 | 4 | 33.3% |
| 2023 | 2 | 16.7% |
| 2024 | 2 | 16.7% |
| 2025partial year | 1 | 8.3% |
Top 7 of 7 technology areas
Overall rank by patents
#22,175
of 50,000 tracked assignees
33.8 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.